EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Conjunctival Melanoma: A Clinical Review and Update

Karam Butt, Rumana Hussain, Sarah E Coupland iD, Yamini Krishna iD

Cancers · 10.09.2024 · 16 (18) · 3121

DOI: 10.3390/cancers16183121 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.09.2024. Verfasst von Karam Butt und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Specialist Ophthalmic Pathology Service, Liverpool Clinical Laboratories, Liverpool University Hospitals NHS Foundation Trust, Liverpool L7 …. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conjunctival melanoma (Co-M) is an aggressive, invasive eye and eyelid cancer. Its global incidence of ~1 in a million is increasing at a rate ratio of ~1.4, but this rises sharply in over 65-year-olds. Although rare, Co-M has a devastating impact on the lives of those who develop it. Co-M is often misdiagnosed or overlooked, leading to vision loss either from the destructive effects of the tumour or side effects of therapy, facial disfigurement from radical surgery, and death from metastases. Due to its rarity, there is limited evidence for diagnosis and management; hence, there is no standardised treatment and not all cases are referred to a specialised ocular oncology centre. Recent progress in cancer immunology and genetics have revolutionised the treatment of cutaneous melanomas, which share some similarities to Co-M. Importantly, a better understanding of Co-M and its precursor lesions is urgently needed to lead to the development of novel targeted and immunotherapies both for local tumour control and disseminated disease. This review aims to provide a comprehensive clinical overview of the current knowledge regarding Co-M, its epidemiology, pathogenesis, presentation, diagnosis and recent changes in the classification of its precursor lesions, management, and recent advances in novel biological therapies for personalised treatment of this disease.

Schlagwörter

Stichwörter der Autor:innen

C-MILconjunctival melanocytic intraepithelial lesionsconjunctival melanomaimmunotherapyocular oncologytargeted therapy

Autor:innen und Institutionen

  • National Specialist Ophthalmic Pathology Service, Liverpool Clinical Laboratories, Liverpool University Hospitals NHS Foundation Trust, Liverpool L7 8YE, UK.
  • St Paul's Eye Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool L7 8YE, UK.
  • Department of Eye and Vision Science, Institute of Life Course and Medical Science, University of Liverpool, Liverpool L7 8TX, UK.

ORCID-Profile: Sarah E Coupland, Yamini Krishna

Zitieren

APA

Butt, K., Hussain, R., Coupland, S. E., & Krishna, Y. (2024). Conjunctival Melanoma: A Clinical Review and Update. Cancers, 16(18), 3121. https://doi.org/10.3390/cancers16183121

Vancouver

Butt K, Hussain R, Coupland SE, Krishna Y. Conjunctival Melanoma: A Clinical Review and Update. Cancers. 2024;16(18):3121. doi:10.3390/cancers16183121

BibTeX
@article{Butt2024,
  author = {Butt, Karam and Hussain, Rumana and Coupland, Sarah E and Krishna, Yamini},
  title = {Conjunctival Melanoma: A Clinical Review and Update},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {18},
  pages = {3121},
  doi = {10.3390/cancers16183121}
}
Kostenlos starten →